Wakefield Asset Management L »

Catalyst Pharmaceutical Partners shares owned by Wakefield Asset Management L

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Wakefield Asset Management L from 13F filings

Historical chart of Wakefield Asset Management L investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Wakefield Asset Management L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Wakefield Asset Management L

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 52k 23.34

More positions owned by Wakefield Asset Management L

Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Core Msci Emkt (IEMG)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Technipfmc (FTI)
Newmont Mining Corporation (NEM)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Expedia Group Com New (EXPE)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Lam Research Corp Com New (LRCX)
Aercap Holdings Nv SHS (AER)
Amphenol Corp Cl A (APH)

View all positions for Wakefield Asset Management L

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Fundsmith
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Renaissance Technologies
Royce & Associates
Arrowstreet Capital, Limited Partnership
Millennium Management
Charles Schwab Investment Management
Invesco
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners